Free tool
Diagnostics stocks
We cover 2 companies grouped under the Diagnostics theme. The median market value in the group is $5.47B. Across the group, the median move over the past trading day is −1.64%. Price change over the past year runs from −11.0% to −7.9% across the middle 80 percent of the group, with a median of −9.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.